What Happened: The FTC is disputing “junk patent listings” for diabetes, weight loss, asthma and COPD drugs. This initiative ...
In an attempt to curb inaccurate patent listings in the Food and ... for medicines they rely on,” FTC Chairwoman Lina Khan ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The US Federal Trade Commission (FTC) has expanded its campaign against so-called ‘junk’ patents intended ... disputing more than 300 patent listings in its Orange Book covering 20 brands ...
GSK has pushed back on US claims it is holding back competition among drugmakers with “junk ... patent listings”. On Wednesday GSK chief executive Emma Walmsley disputed the FTC’s ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
In a warning letter sent to several drugmakers, including Ozempic's Denmark-based manufacturer Novo Nordisk, the FTC announced that it plans to challenge so-called "junk patents" that keep the ...
[3] FTC comment letter part of ongoing agency effort to target anticompetitive conduct ... efforts to dispute “improper” Orange Book patent listings that the agency argues can harm drug ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...
Care.com did not admit or deny wrongdoing in agreeing to settle. The FTC said Care.com enticed customers to buy auto-renewing memberships by overstating the number of jobs, or "gigs," on its ...
Care.com Reaches $8.5 Million US FTC Settlement Over Job Listings, Renewals By Jonathan Stempel (Reuters) -Care.com, a platform for providing in-home care services to children, older adults and ...